<DOC>
	<DOCNO>NCT01124045</DOCNO>
	<brief_summary>The primary objective study compare safety efficacy Durezol™ compare Pred Forte™ treatment inflammation follow cataract surgery pediatric population 0 3 year age .</brief_summary>
	<brief_title>Difluprednate Pediatric Study Treatment Inflammation Post-Cataract Surgery</brief_title>
	<detailed_description>Parents guardian instill patient ' assign study medication day surgery ( Day 0 ) 4 time daily ( QID ) begin day surgery ( Day 1 ) 14 day follow tapering period 14 day ( dependent upon Investigator 's determination adequate response treatment ) . Patients evaluate safety efficacy follow visit : Day 0 ( day surgery ) , Day 1 , Day 8 ± 1 day , Day 15 ± 2 day Day 29 ± 2 day ( end study drug treatment ) . Additional safety visit occur 1 week last dose + 2 day 3 Months + 1 week . No inferential statistical analysis plan study . Data summarize use descriptive statistic .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<criteria>0 3 year age . Undergoing uncomplicated cataract extraction 1 eye without intraocular lens . Informed consent sign parent legal guardian . Other protocoldefined inclusion criterion may apply . Presence active suspect viral , bacterial , fungal disease study eye . Use topical medication study within 7 day prior surgery , except drop need examine eye prepare surgery . Patients posttraumatic cataract . Active uveitis study eye . Ocular neoplasm study eye . Human immunodeficiency virus ( HIV ) ; acquire immunodeficiency syndrome ( AIDS ) . Suspected permanent low vision blindness fellow nonstudy eye . The study eye must patient 's good eye . Patients systemic steroid nonsteroidal antiinflammatory drug . History steroidinduced intraocular pressure ( IOP ) rise . Currently medication ocular hypertension glaucoma study eye . Diabetes . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Cataracts</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Durezol</keyword>
	<keyword>Pred Forte</keyword>
	<keyword>Difluprednate</keyword>
	<keyword>Prednisolone</keyword>
</DOC>